Cargando…
Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage
INTRODUCTION: The transcription factor SOX2 has been identified as a lineage survival oncogene in squamous cell carcinoma and copy number gain is a common event in several human malignancies including head and neck cancer. However, the regulation and function of SOX2 during carcinogenesis as well as...
Autores principales: | Thierauf, Julia, Weissinger, Stephanie E., Veit, Johannes A., Affolter, Annette, Laureano, Natalia K., Beutner, Dirk, Heiduschka, Gregor, Kadletz, Lorenz, Meyer, Moritz, Quaas, Alexander, Plinkert, Peter, Hoffmann, Thomas K., Hess, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875788/ https://www.ncbi.nlm.nih.gov/pubmed/29596469 http://dx.doi.org/10.1371/journal.pone.0194989 |
Ejemplares similares
-
Protein Expression of Folate Receptor Alpha in Adenoid Cystic Carcinoma of the Head and Neck
por: Schnoell, Julia, et al.
Publicado: (2022) -
The Potential Prognostic Value of a Novel Hematologic Marker Fibrinogen-to-Lymphocyte Ratio in Head and Neck Adenoid-Cystic Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021) -
Prognostic Relevance of Thyroid-Hormone-Associated Proteins in Adenoid Cystic Carcinoma of the Head and Neck
por: Schnoell, Julia, et al.
Publicado: (2021) -
Expression of inhibitors of apoptosis proteins in salivary gland adenoid cystic carcinoma: XIAP is an independent marker of impaired cause‐specific survival
por: Schnoell, Julia, et al.
Publicado: (2020) -
Pretherapeutic Serum Albumin as an Outcome Prognosticator in Head and Neck Adenoid-Cystic Carcinoma
por: Friedl, Marlene, et al.
Publicado: (2022)